Policy for Priority Result Reporting

Size: px
Start display at page:

Download "Policy for Priority Result Reporting"

Transcription

1 Policy for Priority Result Reporting Purpose/Introduction The Quest Diagnostics Priority Result Reporting Policy describes the reporting of test results assigned a variable level of Priority (P1, P2, or P3) depending on thresholds established and amended by medical consensus and approval of the Chief Laboratory Officer. The priority result reporting described in this policy is in addition to the regular reporting procedure for all test results (such as printed reports delivered by mail). The provider who requests the test is responsible for providing 24-hour reliable contact information for the purpose of priority reporting. Information may only be provided to someone who indicates they have the authority to accept the communication. We will notify the ordering provider or authorized representative as permitted or required by state and federal law. Thereafter, the provider or authorized representative has the responsibility of interpreting the result in the context of the patient s clinical condition and to take immediate action, if needed. If the person notified is not qualified to make these decisions, they have a responsibility to communicate the information to a qualified person immediately. Priority Level Definitions Priority-1 test results are reported 24 hours/day and 7 days/week and include results considered critical according to the Clinical Laboratory Improvement Amendments of 1988 (CLIA; CFR f) and the CAP Laboratory Accreditation Program. Priority-2 test results are reported 9am to 7pm, 7 days/week and include results that may require attention prior to the receipt of routine laboratory reports. Tests marked Priority 2WD are called during office hours, between 9 am and 4 pm weekdays, or other hours if known to our Client Services team. For facilities that are known to us as a nursing home or hospital, we will use reasonable efforts to promptly communicate these results at any hour of the day, 7 days/week. Priority-3 test results are only verbally communicated to clients with no electronic means of receiving patient reports (e.g., mailed or courier-delivered reports), or clients who have requested P3 reporting in writing. These are test results are generally reported during regular client office hours, e.g. 9am 5pm. The attached Priority Value Table will not be modified (changed, deleted from, or added to) without the signed written request of the client. Sincerely, Stephen C. Suffin, M.D. Quest Diagnostics Vice President & Chief Laboratory Officer Quest Diagnostics Priority Result Reporting Policy (client synopsis) Version 12.0 revised 7/01/14

2 Chemistry / Special Chemistry Priority 1 (called 24 hrs 7 days) Priority 2 (called 9am 7pm 7 days) Ammonia [umol/l] 18 y >200 Amylase [U/L] 300 Bilirubin, total [mg/dl] 2 y y Bilirubin, total [mg/dl] >2 y >20.0 BUN [mg/dl] 100 Calcium, total [mg/dl] Calcium, ionized [mg/dl] 3.2 >6.9 CK MB CK [U/L] 18 y >positive cutoff value (varies with assay) 1000 >18 y 6000 Creatinine [mg/dl] 8.00 Galactose, urine [mg/dl] 2 y >70 Galactose 1 Phosphate [mg/dl packed RBC] 2 y >5.0 Glomerular Basement Membrane Antibody IgG [AI] (Bioplex assay) Glomerular Basement Membrane Antibody IgG [Units] (Inova assay) Glucose, serum [mg/dl] * Glucose results are flagged P1 P3 regardless of ordered test (OGTT, random glucose, serum or plasma). When results are called to the client, the report title of the test result should be made known to the client. >8.0 >40 Glucose, CSF, [mg/dl] <30 < Iron (serum) [mcg/dl] 12 y 500 Lipase [U/L] 180 Magnesium, serum or plasma [mg/dl] Phosphate (as phosphorous), serum or plasma [mg/dl] 1.0 Potassium, serum or plasma [mmol/l] Sodium, serum or plasma [mmol/l] Page 1 of 12

3 Chemistry / Special Chemistry Priority 1 (called 24 hrs 7 days) Priority 2 (called 9am 7pm 7 days) Transferrin, Beta-2 Troponin (I or T) [ng/ml] >cutoff value (Detected) TSH [miu/l] 1 y Uric Acid [mg/dl] >14.0 Viscosity, serum [relative to water] 3.0 Page 2 of 12

4 Hematology / Coagulation / Urinalysis Priority 1 (called 24 hrs 7 days) Priority 2 (called 9am 7pm 7 days) Blasts, absolute number [/ul] Cerebrospinal fluid (CSF) 50,000 on any patient Any abnormal per local Medical Director Coagulation Factors VIII & IX, Activity [%] <5 Coagulation Factor XIII, Activity [%] <20 Coagulation Factor VIII, IX and XI Inhibitor [Bethesda Unit] Blasts >0 (new patient only) >2 Cryoglobulin [%] 3 Fibrinogen Clotting Activity, Clauss Method [mg/dl] <50 Heparin [IU/mL] >2.0 Heparin-Induced Platelet Antibody Serotonin Release Assay [%] 20 ADAMTS13 Activity reflex to Inhibitor (Von Willebrand Factor Protease Cleaving Activity) [%] Glucose, urine (Urinalysis) Hemoglobin [g/dl] Malaria parasites or other organisms (Babesia, Ehrlichia, Trypanosomes etc.) [also appears in Microbiology section] y < y >12 y >12 y for P. falciparum or unspeciated Plasmodium species that are possibly P. falciparum WBC, absolute number [/ul] <1,000 for blood parasites other than P. falciparum Neutrophils, absolute number [/ul] <400 >30,000 Band neutrophils, absolute number [/ul] >10,000 Partial Thromboplastin Time, (aptt) [sec.] Platelet Count, absolute number [/ul] <20,000 2,000,000 Prothrombin Time - International Normalized Ratio (PT-INR) 16 y 20,000 50, or higher 1,000,000 1,999, Reducing Substance (Urinalysis, Clinitest) 2 y Page 3 of 12

5 Microbiology / Serology Priority 1 (called 24 hrs 7 days) Priority 2 (called 9am 7pm 7 days) Aspergillus galactomannan antigen, serum or bronchoalveolar lavage Bacillus anthracis, culture, nucleic acid, or antigen test Bacterial meningitis antigens, CSF Detected Bordetella pertussis, culture, nucleic acid, or antigen Bordetella parapertussis, culture, nucleic acid, or antigen Brucella sp., culture, nucleic acid or antigen test Chlamydia trachomatis, culture, nucleic acid or antigen test Clostridium difficile toxin A/B and GDH Antigen positive, or positive PCR, cytotoxicity assay or toxigenic culture (Note: non-toxigenic strains should not be called) Corynebacterium diphtheriae, nasopharynx culture Cryptococcus antigen, serum or CSF Detected Culture: blood, CSF, any tissue or sterile body fluid (excluding urine) PRELIM: positive any organism <13 y Detected FINAL: positive any organism E coli O157, culture, stool Francisella tularensis, culture, nucleic acid, or antigen test Gram or other stain of direct specimen or antigen detection (blood, CSF, sterile body fluid) Nucleic acid detection (blood, CSF, sterile body fluid), qualitative or quantitative FIRST DETECTION ONLY Gram or other stain of direct specimen or antigen or nucleic acid detection (tissue) for any microorganism for any microorganism except HBV, HCV, HIV except for skin or wound for HBV, HCV, HIV or Detected Page 4 of 12

6 Microbiology / Serology Priority 1 (called 24 hrs 7 days) Priority 2 (called 9am 7pm 7 days) Histoplasma, Blastomyces, Coccidiodes, Paracoccidiodes, Cryptoccocus neoformans or Cryptococcus gattii isolated and/or detected by microscopy, nucleic acid or antigen tests Influenza A and/or B (includes positive H1N1 test results), culture, nucleic acid, or antigen test Legionella sp., culture, nucleic acid, or antigen test Malaria parasites or other organisms (Babesia, Ehrlichia, Trypanosomes etc.) MRSA culture: Patients in institutional settings ONLY for P. falciparum or unspeciated Plasmodium species that are possibly P. falciparum for blood parasites other than P. falciparum MRSA, PCR or other nucleic acid test Detected Mucormycosis/Zygomycosis involving sinonasal area Mycobacteria all sp., stain or direct specimen nucleic acid test for M tuberculosis, initial detection Mycobacteria all sp., culture, initial detection and final identification. Mycobacteria tuberculosis, susceptibilities, resistant to 2 or more drugs Neisseria gonorheoeae, culture or nucleic acid test Resistant 2 <13y Nocardia species Norovirus PCR or Antigen Pneumocystis jiroveci (carinii), stain or antigen or nucleic acid test Respiratory syncytial virus (RSV), culture, nucleic acid or antigen test Rotavirus, antigen test Shiga Toxin, EIA Detected 3 y >3 y Page 5 of 12

7 Microbiology / Serology Priority 1 (called 24 hrs 7 days) Priority 2 (called 9am 7pm 7 days) Stool Culture, Shigella sp., Listeria sp., Salmonella sp., Campylobacter sp., Vibrio sp., and/or Yersinia enterocolitica Streptococcus, Group A, wound culture Streptococcus, Group B, culture or nucleic acid test <1 y Ureaplasma urealyticum, culture, respiratory <1 y Vancomycin Intermediate or Resistant Staphylococcus aureus (VISA or VRSA) Vancomycin I or R VRE culture VRE PCR or nucleic acid test Detected Yersinia pestis, culture, nucleic acid, or antigen test Page 6 of 12

8 TDM / Toxicology Priority 1 (called 24 hrs 7 days) Priority 2 (called 9am 7pm 7 days) Acetaminophen [mg/l] 50 Acetone [mg/dl] 50 Amikacin, random [mg/l] >30.0 Amikacin, peak [mg/l] >30.0 Amikacin, trough [mg/l] >8.0 Amitriptyline + Nortriptyline, total [mcg/l] Amobarbital [mg/l] Arsenic, blood [mcg/l] >60 Butalbital [mg/l] >10.0 Cadmium, blood [mcg/l] Cadmium, 24hr urine [mcg/l] >10.0 Caffeine [mg/l] 50.0 <1 y y Carbamazepine, total [mg/l] Carboxyhemoglobin [% of total Hgb] Chloramphenicol, random [mg/l] >25.0 Chloramphenicol, peak [mg/l] >25.0 Chloramphenicol, trough [mg/l] >20.0 Chlordiazepoxide and Metabolite and Desmethylchlordiazepoxide, total [mg/l] >5.0 Chlorpromazine [ng/ml] y Chlorpromazine [ng/ml] 750 <18 y Clomipramine and Metabolite, total [ng/ml] 600 Clozapine [ng/ml] 900 Clorazepate as Nordiazepam [mg/l] >2.0 Cobalt, blood [mcg/l] 400 Cobalt, urine [mcg/l] 250 Cyanide [mg/l] Cyclosporine, trough [mcg/l] Desethylamiodarone [mcg/ml] >2.5 Desipramine [mcg/l] Diazepam and Nordiazepam, total [mg/l] Digoxin [mcg/l] Page 7 of 12

9 TDM / Toxicology Priority 1 (called 24 hrs 7 days) Priority 2 (called 9am 7pm 7 days) Disopyramide [mg/l] Doxepin + Nordoxepin, total [mcg/l] Ethanol [mg/dl] 250 Ethosuximide [mg/l] Ethylene glycol [mg/l] 100 Flecainide [mg/l] 1.0 Fluoxetine [mcg/l] >469 Fluphenazine [mcg/l] Norfluoxetine [mcg/l] >446 Gentamicin, random [mg/l] >10.0 Gentamicin, peak [mg/l] >10.0 Gentamicin, trough [mg/l] >2.0 Haloperidol, serum [ng/ml] >20 Ibuprofen [mg/l] Imipramine or Desipramine, total [mcg/l] Isopropanol [mg/dl] 50 Lead, blood [mcg/dl] <18 y 45 <6 y y >40 Lead, 24hr urine [mcg/l] 120 Levetiracetam, peak [mg/l] >70 Levetiracetam, trough [mg/l] >37 Lidocaine [mg/l] Lithium [mmol/l] Meconium Drug Testing (confirmation) Mephobarbital [mg/l] Mercury, blood [mcg/l] >13 Mercury, urine, 24 hr [mcg/l] Mercury, urine, random [mcg/g creatinine] Mesoridazine [mg/l] >1.4 Methanol [mg/dl] 5 Methemoglobin [% of total Hgb] Methotrexate at 24 h [µmol/l] 5.00 Methsuximide, as Normethsuximide [mg/l] >40.0 Page 8 of 12

10 TDM / Toxicology Priority 1 (called 24 hrs 7 days) Priority 2 (called 9am 7pm 7 days) Mexiletine [mg/l] Mycophenolic Acid [mcg/ml] < >3.5 Mycophenolic Acid Glucoronide [mcg/ml] <35.0 Nortriptyline [mcg/l] Phenobarbital [mg/l] Phenytoin [mg/l] Phenytoin, free [mg/l] >3.0 Primidone [mg/l] > Procainamide [mg/l] Procainamide + NAPA, total [mg/l] >30.0 Protriptyline [mcg/l] > Propafenone [mg/l] >2.0 Quinidine [mg/l] Salicylates [mg/l] 400 Sirolimus (Rapamycin) [mcg/l] < Tacrolimus (FK 506) [mcg/l] < >20.0 Theophylline [mg/l] <6 m >10.0 Theophylline [mg/l] 6 m m Thioridazine [mg/l] >2.6 Tobramycin, random [mg/l] >10.0 Tobramycin, peak [mg/l] >10.0 Tobramycin, trough [mg/l] >2.0 Thallium, blood [mcg/l] Thallium, urine, 24 hr [mcg/l] Trazodone [mcg/l] >2,100 Valproic Acid [mg/l] Vancomycin, random [mg/l] Vancomycin, peak [mg/l] Vancomycin, trough [mg/l] 80.0 >20.0 Zonisamide [mg/l] >40 Page 9 of 12

11 Genetic Testing Analyte Ashkenazi Jewish Panel (4, 11, or 18 test) Bloom Syndrome DNA Mutation Analysis Canavan Disease Mutation Analysis Cystic Fibrosis Screen Familial Dysautonomia Mutation Analysis Fanconi's Anemia DNA Mutation Analysis Gaucher Disease, DNA Mutation Analysis Glycogen Storage Disease Type Ia Mutation Analysis Maple Syrup Disease (MSUD) Mutation Analysis (Ashkenazi Jewish) Mucolipidosis Type IV Mutation Analysis Niemann-Pick Disease Mutation Analysis Tay-Sachs Disease Mutation Analysis Amniotic fluid open neural tube defect screen XSense, Fragile X with Reflex Maternal Serum Biochemical Screening SMA Carrier Screen SMA Diagnostic Test Achondroplasia Mutation Alpha-1 Antitrypsin (AAT) Mutation Analysis Alpha-Globin Common Mutation Analysis Alpha-Globin Gene Deletion or Duplication Beta Globin Gene Dosage Analysis Beta-Globin Complete CAH (21-Hydroxylase Deficiency) Common Mutations Cystic Fibrosis D1152H Mutation Analysis Cystic Fibrosis Gene Deletion or Duplication Dihydrolipoamide Dehydrogenase Deficiency Dihydropyrimidine Dehydrogenase (DPD) Gene Mutation Analysis Factor V Leiden Factor XI Mutation Analysis (Ashkenazi Jewish) Familial Hyperinsulinism Priority 2WD (called 9am 5pm Mon-Fri ONLY) Result Heterozygous for Mutation or Not Interpretable Note: Homozygous disease states are handled by the Genetic counseling team in accordance with SOP # 245SM029 MOM value 2.0 MOM Gray zone, pre-mutation or full mutation affected result MSS Interpretation- Screen positive for ONTD, Down syndrome and/or trisomy 18 or High risk for Down syndrome and/or trisomy 18 One copy of the SMN1 gene detected One copy of the SMN1 gene detected positive Homozygous positive and positive for z and s for MED, FILL, SEA, THAI, ALPHA 20.5; for at least 2 gene deletions Deletion of 2, 3 or 4 alpha globin genes positive positive positive positive positive Heterozygous and homozygous positive Homozygous positive Page 10 of 12

12 Genetic Testing Analyte Familial Mediterranean Fever Mutation Analysis Galactosemia Mutation Analysis Huntington Disease Mutation Analysis Joubert Syndrome Long Chain Acyl-CoA Dehydrogenase (LCHAD) Mutation Analysis Medium Chain Acyl-CoA Dehydrogenase (MCAD) Mutation Analysis MEN2 and FMTC Mutations, Exons 10, 11, Nemaline Myopathy Phenylketonuria (PKU) Mutation Analysis Prader-Willi/Angelman Syndrome, DNA Methylation Analysis Prothrombin (Factor II) 20210G>A Mutation Analysis Rett Syndrome Mutation Analysis Rett Syndrome Rearrangement (Deletion or uplication TPMT Genotype UGT1A1 Gene Polymorphism (TA Repeat) Usher Syndrome Type IF Usher Syndrome Type III Walker-Warburg Syndrome Y Chromosome Microdeletion, DNA Analysis Priority 2WD (called 9am 5pm Mon-Fri ONLY) Result positive positive Affected, intermediate positive positive positive positive positive Homozygous positive positive positive Intermediate metabolizer, poor metabolizer Homozygous for the ta7 polymorphism positive Page 11 of 12

13 Pathology / Hematopathology Priority 1 (called 24 hrs 7 days) Ordered Test Interpretation Interpretation Priority 2 (called 9am 7pm 7 days) Herpes changes, if pregnancy indicated in LIS Gyn Cytology (Pap) Adenocarcinoma in situ Suspicious for malignancy for malignancy** Non Gyn Cytology Suspicious for malignancy for malignancy** Hematopathology (including Flow Cytometry, FISH, and Molecular) First time diagnosis of acute promyelocytic leukemia for acute leukemia (initial or recurrence) Tissue Biopsy Frozen section results Presence of adipose tissue in an endometrial biopsy POC without identifiable placental villi or fetal parts Suspicious for malignancy** for malignancy** Significant unexpected surgical pathology findings as determined by pathologist ** Excluding squamous/basal cell skin carcinomas and/or re-excision of known recently diagnosed malignancy but includes cases in which biopsy is a follow-up to cytology report. It is not intended that pre-malignant conditions such as CIN3, high grade PIN, complex endometrial hyperplasia, etc. be considered "Suspicious for Malignancy" unless the pathologist has made an additional comment to that effect. Page 12 of 12

UNIVERSITY OF KENTUCKY HOSPITAL LABORATORIES 3/26/14 Lexington, KY Page 1 of 6

UNIVERSITY OF KENTUCKY HOSPITAL LABORATORIES 3/26/14 Lexington, KY Page 1 of 6 Lexington, KY Page 1 of 6 Affected Sites: X Enterprise Chandler Good Samaritan CRITICAL VALUES: Critical Values are defined as an analytic result that suggests a clinical condition that may be lifethreatening

More information

CRITICAL/VITAL LABORATORY RESULTS NOTIFICATION

CRITICAL/VITAL LABORATORY RESULTS NOTIFICATION TriHealth Laboratories Page 1 of 6 CRITICAL/VITAL LABORATORY RESULTS NOTIFICATION PURPOSE This laboratory-specific policy supplements the TriHealth Corporate Policy #02_37.00: Critical Results Reporting.

More information

UNIVERSITY OF CONNECTICUT HEALTH CENTER CORRECTIONAL MANAGED HEALTH CARE POLICY AND PROCEDURES FOR USE WITHIN THE CONNECTICUT DEPARTMENT OF CORRECTION

UNIVERSITY OF CONNECTICUT HEALTH CENTER CORRECTIONAL MANAGED HEALTH CARE POLICY AND PROCEDURES FOR USE WITHIN THE CONNECTICUT DEPARTMENT OF CORRECTION UNIVERSITY OF CONNECTICUT HEALTH CENTER CORRECTIONAL MANAGED HEALTH CARE POLICY AND PROCEDURES FOR USE WITHIN THE CONNECTICUT DEPARTMENT OF CORRECTION NUMBER: P 1.01 Page 1 of 1 PATIENT SAFETY SYSTEM/PSS:

More information

PROFICIENCY TESTING. Clinical Laboratory Improvement Amendments (CLIA) DOs and DON Ts. Brochure # 8

PROFICIENCY TESTING. Clinical Laboratory Improvement Amendments (CLIA) DOs and DON Ts. Brochure # 8 Clinical Laboratory Improvement Amendments (CLIA) Brochure # 8 PROFICIENCY TESTING DOs and DON Ts NOTE: Congress passed the Clinical Laboratory Improvement Amendments (CLIA) in 1988 establishing quality

More information

Guideline for Reporting Laboratory Test Results CLP 025 (replaces C020)

Guideline for Reporting Laboratory Test Results CLP 025 (replaces C020) Guideline for Reporting Laboratory Test Results CLP 025 (replaces C020) Revised September, 2009 1. Purpose The purpose of this Guideline is to establish reporting protocols which will enhance patient safety

More information

The Medical Laboratory Licensing Regulations, 1995

The Medical Laboratory Licensing Regulations, 1995 1 The Medical Laboratory Licensing Regulations, 1995 being Chapter M-9.2 Reg 1 (effective March 1, 1996) as amended by Saskatchewan Regulations 23/2004, 87/2007 and 88/2013. NOTE: This consolidation is

More information

The CPT code for Human papillomavirus (HPV) has changed from 87621 to 87624. This code (87624) covers testing for HPV High Risk genotypes.

The CPT code for Human papillomavirus (HPV) has changed from 87621 to 87624. This code (87624) covers testing for HPV High Risk genotypes. January 2015 2015 CPT Code Updates Dear Client: The American Medical Association (AMA) publishes the Current Procedural Terminology (CPT) Coding Manual on an annual basis. For 2015, the AMA made several

More information

***Before submitting your application, please review the checklist on the last page.***

***Before submitting your application, please review the checklist on the last page.*** Maryland Department of Health and Mental Hygiene Office of Health Care Quality Laboratory Licensing Programs Spring Grove Center Bland Bryant Building 55 Wade Avenue, Catonsville, MD 21228 Phone: 410.402.8025

More information

No. Type of Sample Test Method

No. Type of Sample Test Method Allergy and Immunology Laboratory, Department of Pediatrics 1. Clotted Blood Specific IgE Fluorescence Enzyme Immunoassay : ImmunoCAP 100 Endocrinology Laboratory, Department of Pediatrics 2. Serum Growth

More information

Microbiology Specimen Collection Instructions. Alphabetical List of Microbiology Tests

Microbiology Specimen Collection Instructions. Alphabetical List of Microbiology Tests Page 1 of 8 Alphabetical List of Tests Test/Specimen Type Collection Table Referred out Abscess aspirate, wound Acanthamoebae Parasitology Acinetobactor screening Adenovirus Serology AFB Stain only Amoebiasis

More information

Specimen Collection Guide

Specimen Collection Guide Specimen Collection Guide pathology.mater.org.au Specimen Collection Guide This chart indicates the specimen required for most frequently requested tests. If the desired test is not listed here please

More information

Subpart H--Participation in Proficiency Testing for Laboratories Performing Nonwaived Testing

Subpart H--Participation in Proficiency Testing for Laboratories Performing Nonwaived Testing Subpart H--Participation in Proficiency Testing for Laboratories Performing Nonwaived Testing Subpart H - Guidelines - General By law, proficiency testing (PT) programs are evaluated initially for CMS

More information

If your doctor has ordered laboratory tests, it s natural

If your doctor has ordered laboratory tests, it s natural A Patient s Guide to Clinical oratory Testing at Kingman Regional Medical Center If your doctor has ordered laboratory tests, it s natural to have questions about why and how the tests are performed. This

More information

CAP Accreditation Checklists 2015 Edition

CAP Accreditation Checklists 2015 Edition CAP Accreditation Checklists 2015 Edition The College of American Pathologists (CAP) accreditation checklists contain the CAP accreditation program requirements, developed on more than 50 years of insight

More information

Room Temp: 8 Hr. Room Temp: 8Hr. Room Temp: ASAP. Refrigerated (2-8C): 3D. Room Temp: ASAP. Refrigerated (2-8C): 3D

Room Temp: 8 Hr. Room Temp: 8Hr. Room Temp: ASAP. Refrigerated (2-8C): 3D. Room Temp: ASAP. Refrigerated (2-8C): 3D Diabetes Chem Panel (Glu, Trig, Chol, HDL, LDL, Chol:HDL Ratio, AST, ALT, BUN, Creat, GFR, Na, K, Cl, CO2, Ca) ANMC Lab Test Requirements Updated 4/7/15 Key: Room Temp (20-25C), Refrigerated (2-8C), (-15

More information

Hepatitis C. Laboratory Tests and Hepatitis C

Hepatitis C. Laboratory Tests and Hepatitis C Hepatitis C Laboratory Tests and Hepatitis C If you have hepatitis C, your doctor will use laboratory tests to check your health. This handout will help you understand what the major tests are and what

More information

CANADIAN RULE BASED CLASSIFICATION SYSTEM (IVDD) Life Sciences British Columbia NRC-Industry Research Assistance Program

CANADIAN RULE BASED CLASSIFICATION SYSTEM (IVDD) Life Sciences British Columbia NRC-Industry Research Assistance Program CANADIAN RULE BASED CLASSIFICATION SYSTEM (IVDD) Life Sciences British Columbia NRC-Industry Research Assistance Program Health Canada Regulations on Medical Devices Vancouver, B.C. October 29, 2007 Nancy

More information

Diagnostic Detectives: Medical Laboratory Professionals. A Closer Look at Careers in Clinical Laboratory Science (Medical Technology)

Diagnostic Detectives: Medical Laboratory Professionals. A Closer Look at Careers in Clinical Laboratory Science (Medical Technology) Diagnostic Detectives: Medical Laboratory Professionals A Closer Look at Careers in Clinical Laboratory Science (Medical Technology) Medical Laboratory Facts A behind-the the-scenes, highly skilled team

More information

Compliance and Regulatory Information Section 2. Reflex Testing

Compliance and Regulatory Information Section 2. Reflex Testing Compliance and Regulatory Information Section 2 Reflex Testing Reflex Tests refer to the additional testing, which occurs when initial test results are positive or outside of normal parameters and indicate

More information

Bureau of Laboratory Quality Standards Page 1 of 6

Bureau of Laboratory Quality Standards Page 1 of 6 Biomolecular 1. Plasma HIV (RNA) Reverse Transcriptase PCR 2. Plasma HIV Viral Load (RNA) 3. Plasma HIV-1 Drug Resistance (RNA) - Reverse Transcriptase PCR - Sequencing 2 Genes (Protease 4. and Body Fluid

More information

HealthEast Medical Laboratory

HealthEast Medical Laboratory HealthEast Medical Laboratory Long-Term Care / Assisted Living 45 West 10 th Street St. Paul, MN 55102-1004 Telephone: 651-232-3500 800-706-3712 Fax: 651-232-3370 Accreditation / Identification Numbers:

More information

Genetic Screening and Pregnancy: Selecting the Best Test for Your Patient

Genetic Screening and Pregnancy: Selecting the Best Test for Your Patient Genetic Screening and Pregnancy: Selecting the Best Test for Your Patient Britton Rink, MD, MS The Ohio State University Division of Maternal Fetal Medicine ACOG Practice Bulletin January 2007 Screening

More information

Annex to the Accreditation Certificate D-ML-13455-01-00 according to DIN EN ISO 15189:2014

Annex to the Accreditation Certificate D-ML-13455-01-00 according to DIN EN ISO 15189:2014 Deutsche Akkreditierungsstelle GmbH German Accreditation Body Annex to the Accreditation Certificate D-ML-13455-01-00 according to DIN EN ISO 15189:2014 Period of validity: 22.04.2015 to 25.09.2018 Date

More information

STATE UNIVERSITY OF NEW YORK COLLEGE OF TECHNOLOGY CANTON, NEW YORK COURSE OUTLINE VSCT 210 VETERINARY MICROBIOLOGY

STATE UNIVERSITY OF NEW YORK COLLEGE OF TECHNOLOGY CANTON, NEW YORK COURSE OUTLINE VSCT 210 VETERINARY MICROBIOLOGY STATE UNIVERSITY OF NEW YORK COLLEGE OF TECHNOLOGY CANTON, NEW YORK COURSE OUTLINE VSCT 210 VETERINARY MICROBIOLOGY Prepared By: Mary O Horo Loomis, DVM SCHOOL OF SCIENCE, HEALTH AND CRIMINAL JUSTICE VETERINARY

More information

Toxicology CPT Code Changes for 2016

Toxicology CPT Code Changes for 2016 Beginning January 1, 2016, CMS deleted all 2015 drug testing G codes and will continue to not recognize the AMA CPT codes for drug testing. CMS created three G codes for presumptive testing and four G

More information

Veterinary Testing. Classes of Test

Veterinary Testing. Classes of Test Veterinary Testing Classes of Test July 2014 Copyright National Association of Testing Authorities, Australia 2014 This publication is protected by copyright under the Commonwealth of Australia Copyright

More information

Medical Laboratory Technology Program. Student Learning Outcomes & Course Descriptions with Learning Objectives

Medical Laboratory Technology Program. Student Learning Outcomes & Course Descriptions with Learning Objectives Medical Laboratory Technology Program Student Learning Outcomes & Course Descriptions with Learning Objectives Medical Laboratory Technology Student Learning Outcomes All Colorado Mesa University associate

More information

KEY CHAPTER 14: BLOOD OBJECTIVES. 1. Describe blood according to its tissue type and major functions.

KEY CHAPTER 14: BLOOD OBJECTIVES. 1. Describe blood according to its tissue type and major functions. KEY CHAPTER 14: BLOOD OBJECTIVES 1. Describe blood according to its tissue type and major functions. TISSUE TYPE? MAJOR FUNCTIONS connective Transport Maintenance of body temperature 2. Define the term

More information

Streptococcus pneumoniae IgG AB (13 Serotypes), MAID... 7

Streptococcus pneumoniae IgG AB (13 Serotypes), MAID... 7 Volume 12 December 2011 Table of Contents Summary of Test Changes... 3 Test Changes... 6 Human Anti-Mouse AB (HAMA), ELISA... 6 Hepatitis E Antibody (IgG, IgM)... 6 Hepatitis E Antibody (IgG)... 6 Hepatitis

More information

July 2015 - Monthly Update, Quest Diagnostics Nichols Institute, Valencia

July 2015 - Monthly Update, Quest Diagnostics Nichols Institute, Valencia TEST CHANGES Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Former Test Name Effective Date

More information

COMMUNICATION OF PATHOLOGY RESULTS

COMMUNICATION OF PATHOLOGY RESULTS Principle To define provide guidelines for notification and documentation of critical values, corrected results, and significant or unexpected surgical pathology results. Policy Statement A critical laboratory

More information

LABORATORY MEDICINE CATEGORY LIST. CATEGORY I Laboratories, Vested Interest Laboratory and Hospitals

LABORATORY MEDICINE CATEGORY LIST. CATEGORY I Laboratories, Vested Interest Laboratory and Hospitals LABORATORY MEDICINE CATEGORY LIST Updated to July 3, 2012 CATEGORY I Laboratories, Vested Interest Laboratory and Hospitals The following tests are restricted to laboratories, vested interest laboratories

More information

Annex to the Accreditation Certificate D-PL-14139-01-00 according to DIN EN ISO/IEC 17025:2005

Annex to the Accreditation Certificate D-PL-14139-01-00 according to DIN EN ISO/IEC 17025:2005 Deutsche Akkreditierungsstelle GmbH Annex to the Accreditation Certificate D-PL-14139-01-00 according to DIN EN ISO/IEC 17025:2005 Period of validity: 26.10.2015 to 25.10.2020 Date of issue: 26.10.2015

More information

Genetic Testing in Research & Healthcare

Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research and Healthcare Human genetic testing is a growing science. It is used to study genes

More information

Quality Control Products & Services Catalog

Quality Control Products & Services Catalog Bio-Rad Laboratories quality control 2009 2010 Edition Quality Control Products & Services Catalog Contents of Catalog New Products.... 4 How to Place an Order... 5 Product Support / Technical Service...

More information

LABORATORY and PATHOLOGY SERVICES

LABORATORY and PATHOLOGY SERVICES LABORATORY and PATHOLOGY SERVICES Policy Neighborhood Health Plan reimburses participating clinical laboratory and pathology providers for tests medically necessary for the diagnosis, treatment and prevention

More information

Directory of Laboratory Services 2013-2014 1 st edition Contact Information

Directory of Laboratory Services 2013-2014 1 st edition Contact Information Palomar Health Laboratory Services Palomar Medical Center Pomerado Hospital Palomar Health Downtown Campus 2185 West Citracado Pkwy, 15615 Pomerado Road, 555 E. Valley Pkwy, Escondido, CA 92029 Poway CA,

More information

LABORATORY DATA REPORTING MANUAL

LABORATORY DATA REPORTING MANUAL Pennsylvania Health Care Cost Containment Council September 2015 Version 2015.9.1 225 Market Street, Suite 400, Harrisburg, PA 17101 Phone: 717-232-8958 Fax: 717-772-1401 http://www.phc4.org Table of Contents

More information

MEDICAL NUTRITION THERAPY (MNT) CLINICAL NUTRITION THERAPY Service Time CPT Code

MEDICAL NUTRITION THERAPY (MNT) CLINICAL NUTRITION THERAPY Service Time CPT Code MEDICAL NUTRITION THERAPY (MNT) CLINICAL NUTRITION THERAPY Service Time CPT Code Initial Assessment And Intervention This Code Can Be Used Only Once A Year For First Appointment Medical Nutrition Therapy

More information

Reconsideration Code 86386. Reconsideration Code Description Nuclear Matrix Protein 22 (NMP22), qualitative

Reconsideration Code 86386. Reconsideration Code Description Nuclear Matrix Protein 22 (NMP22), qualitative Calendar Year 2013 Centers for Medicare and Medicaid Services (CMS) New and Reconsidered Clinical Laboratory Fee Schedule (CLFS) Test Codes And Final Payment Determinations Reconsideration Code 86386 Reconsideration

More information

MEDICAL MICROBIOLOGY 603 OR POPULATION HEALTH SCIENCES 603 CLINICAL AND PUBLIC HEALTH MICROBIOLOGY January 18-May 6, 2011

MEDICAL MICROBIOLOGY 603 OR POPULATION HEALTH SCIENCES 603 CLINICAL AND PUBLIC HEALTH MICROBIOLOGY January 18-May 6, 2011 MEDICAL MICROBIOLOGY 603 OR POPULATION HEALTH SCIENCES 603 CLINICAL AND PUBLIC HEALTH MICROBIOLOGY January 18-May 6, 2011 Lectures: M, W, F 1:20-2:30 P.M. ( All lectures will be ~ 70 Minutes ) Office Hours

More information

CLSI Documents and ISO Quality Documents

CLSI Documents and ISO Quality Documents CLSI Documents and ISO Quality Documents Updated June 2014 950 West Valley Road, Suite 2500, Wayne, PA 19087 P: 610.688.0100 Toll Free (US): 877.447.1888 F: 610.688.0700 E: customerservice@clsi.org Quality

More information

Proteins. Protein Trivia. Optimizing electrophoresis

Proteins. Protein Trivia. Optimizing electrophoresis Proteins ELECTROPHORESIS Separation of a charged particle in an electric field Michael A. Pesce, Ph.D Department of Pathology New York-Presbyterian Hospital Columbia University Medical Center Rate of migration

More information

cobas c 311 analyzer

cobas c 311 analyzer cobas c 311 analyzer cobas brand Roche Diagnostics introduces the cobas brand as the umbrella for products used to complete or expand the screening, diagnostic and monitoring applications of the professional

More information

Canadian Public Health Laboratory Network. Core Functions of Canadian Public Health Laboratories

Canadian Public Health Laboratory Network. Core Functions of Canadian Public Health Laboratories Canadian Public Health Laboratory Network Core Functions of Canadian Public Health Laboratories Canadian Public Health Laboratory Network The CPHLN Core Functions of Canadian Public Health Laboratories

More information

Quality Consultant for Oregon Medical Laboratories

Quality Consultant for Oregon Medical Laboratories F E A T U R E Karen Dalton-Beninato Critical Value tifications Are Never Welcome News Quality Consultant for Oregon Medical Laboratories Vivian Benfield, MT(ASCP)SBB, describes a memorable case: Our client

More information

Acute Pancreatitis. Questionnaire. if yes: amount (cigarettes/day): since when (year): Drug consumption: yes / no if yes: type of drug:. amount:.

Acute Pancreatitis. Questionnaire. if yes: amount (cigarettes/day): since when (year): Drug consumption: yes / no if yes: type of drug:. amount:. The physical examination has to be done AT ADMISSION! The blood for laboratory parameters has to be drawn AT ADMISSION! This form has to be filled AT ADMISSION! Questionnaire Country: 1. Patient personal

More information

Carrier Screening For Genetic Diseases Preconception Consent (Female and/or Male Partner)

Carrier Screening For Genetic Diseases Preconception Consent (Female and/or Male Partner) Carrier Screening For Genetic Diseases Preconception Consent (Female and/or Male Partner) The goal of our practice at ARMS is to make sure that you receive optimal care to improve your chances of having

More information

BIOCHEMISTRY DEPARTMENT

BIOCHEMISTRY DEPARTMENT ALBUMIN 33 46 g/l ALK PHOSPHATASE Up to 11 months Male 133 426 U/L Female 196 553 U/L 11+ months 2 years Male 133 287 U/L Female 196 510 U/L 2+ 8 years Male 133 287 U/L Female 196 426 U/L 8+ 11 years Male

More information

2.0 Rationale, Purpose and Scope... 5. 4.0 Definitions... 6. 5.0 General Principles... 7

2.0 Rationale, Purpose and Scope... 5. 4.0 Definitions... 6. 5.0 General Principles... 7 Table of Contents Principles of IVD Medical Devices Classification 1.0 Introduction... 4 2.0 Rationale, Purpose and Scope... 5 2.1 Rationale... 5 2.2 Purpose... 5 2.3 Scope... 5 3.0 References... 5 4.0

More information

Bleeding disorders or haemorrhagic diatheses are a group of disorders characterised by defective haemostasis with abnormal bleeding.

Bleeding disorders or haemorrhagic diatheses are a group of disorders characterised by defective haemostasis with abnormal bleeding. Bleeding disorders or haemorrhagic diatheses are a group of disorders characterised by defective haemostasis with abnormal bleeding. Bleeding may be spontaneous in the form of small haemorrhages into the

More information

New from Specialty. effective March 25, 2003 or as noted. 1515 Alpha-1-Antitrypsin GenotypR Component Method Reference Range

New from Specialty. effective March 25, 2003 or as noted. 1515 Alpha-1-Antitrypsin GenotypR Component Method Reference Range 2211 Michigan Avenue Santa Monica, CA 90404 800-421-4449 Specialty Laboratories is pleased to offer two new genetic tests (Alpha-1-Antitrypsin, Plasminogen Activator Inhibitor), a new therapeutic monitoring

More information

UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO bmparson@gundersenhealth.org Gundersen Health System Center for Cancer and

UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO bmparson@gundersenhealth.org Gundersen Health System Center for Cancer and UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO bmparson@gundersenhealth.org Gundersen Health System Center for Cancer and Blood Disorders La Crosse, WI UNDERSTANDING MULTIPLE

More information

Optional Tests Offered Before and During Pregnancy

Optional Tests Offered Before and During Pregnancy Plano Women s Healthcare Optional Tests Offered Before and During Pregnancy Alpha-Fetoprotein Test (AFP) and Quad Screen These are screening tests that can assess your baby s risk of having such birth

More information

Thrombophilia. Steven R. Lentz, M.D. Ph.D. Carver College of Medicine The University of Iowa May 2003

Thrombophilia. Steven R. Lentz, M.D. Ph.D. Carver College of Medicine The University of Iowa May 2003 Thrombophilia Steven R. Lentz, M.D. Ph.D. Carver College of Medicine The University of Iowa May 2003 Thrombophilia Hereditary and acquired risk factors for thrombosis Venous thromboembolism Arterial thromboembolism

More information

Reference Range: 0.5-1.6 mmol/l (arterial) 0.7-2.1 mmol/l (venous) CPT Code: 83605

Reference Range: 0.5-1.6 mmol/l (arterial) 0.7-2.1 mmol/l (venous) CPT Code: 83605 LACTIC ACID Fasting, arterial specimen preferred. Please note whether arterial or venous. 0.5 ml heparinized plasma. Green top or PST must be drawn, placed on ice, and spun within 15 minutes. Immediately

More information

Liver Function Tests. Dr Stephen Butler Paediatric Advance Trainee TDHB

Liver Function Tests. Dr Stephen Butler Paediatric Advance Trainee TDHB Liver Function Tests Dr Stephen Butler Paediatric Advance Trainee TDHB Introduction Case presentation What is the liver? Overview of tests used to measure liver function RJ 10 month old European girl

More information

Medical Devices; Exemptions From Premarket Notifications; Class II Devices; Autosomal

Medical Devices; Exemptions From Premarket Notifications; Class II Devices; Autosomal This document is scheduled to be published in the Federal Register on 10/27/2015 and available online at http://federalregister.gov/a/2015-27198, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

the central lab of choice for investigative sites and sponsors www.labconnectllc.com

the central lab of choice for investigative sites and sponsors www.labconnectllc.com the central lab of choice for investigative sites and sponsors www.labconnectllc.com Overview The LabConnect difference. LabConnect begins by developing a uniquely tailored laboratory services plan for

More information

i STAT Creatinine Chemistry China Basin

i STAT Creatinine Chemistry China Basin Creatinine is measured amperometrically. Creatinine is hydrolyzed to creatine in a reaction catalyzed by the enzyme creatinine amidohydrolase. Creatine is then hydrolyzed to sarcosine in a reaction catalyzed

More information

ILLINOIS DEPARTMENT OF CENTRAL MANAGEMENT SERVICES CLASS SPECIFICATION CLINICAL LABORATORY TECHNICIAN SERIES

ILLINOIS DEPARTMENT OF CENTRAL MANAGEMENT SERVICES CLASS SPECIFICATION CLINICAL LABORATORY TECHNICIAN SERIES ILLINOIS DEPARTMENT OF CENTRAL MANAGEMENT SERVICES CLASS SPECIFICATION CLINICAL LABORATORY TECHNICIAN SERIES CLASS TITLE POSITION CODE CLINICAL LABORATORY TECHNICIAN I 08215 CLINICAL LABORATORY TECHNICIAN

More information

Coding and Payment Guide for Laboratory Services. An essential coding, billing, and payment resource for laboratory and pathology services

Coding and Payment Guide for Laboratory Services. An essential coding, billing, and payment resource for laboratory and pathology services Coding and Payment Guide for Laboratory Services An essential coding, billing, and payment resource for laboratory and pathology services Contents Introduction............................... 1 Coding Systems...............................

More information

Alberta Newborn Metabolic Screening Program. POLICY DOCUMENT March 2010

Alberta Newborn Metabolic Screening Program. POLICY DOCUMENT March 2010 Alberta Newborn Metabolic Screening Program POLICY DOCUMENT March 2010 Table of Revisions Version Revision Date Revision History 1.0 2010-05-31 Document released. 1.1 2011-01-10 Program Scope revised,

More information

Selected Normal Pediatric Laboratory Values

Selected Normal Pediatric Laboratory Values Selected Normal Pediatric Laboratory Values All laboratory values listed are approximate. Consult your local laboratory for guidelines as to normal values for the specific testing procedures used. NORMAL

More information

Organisation of Biochemical Genetic Testing in Estonia

Organisation of Biochemical Genetic Testing in Estonia Organisation of Biochemical Genetic Testing in Estonia Katrin Õunap Department of Pediatrics, University of Tartu Department of Genetics, Tartu University Hospital Basel, 09 th May 2008 ESTONIA 1,35 million

More information

COBAS INTEGRA 400 plus

COBAS INTEGRA 400 plus COBAS INTEGRA 400 plus COBAS INTEGRA 400 plus Advantages Real security of results with the COBAS INTEGRA clot detection system cobas c packs make reagent preparation a task of the past Workflow consolidation

More information

Albumin. Prothrombin time. Total protein

Albumin. Prothrombin time. Total protein Hepatitis C Fact Sheet February 2016 www.hepatitis.va.gov Laboratory Tests and Hepatitis If you have hepatitis C, your doctor will use laboratory tests to about learn more about your individual hepatitis

More information

REI Pearls: Pitfalls of Genetic Testing in Miscarriage

REI Pearls: Pitfalls of Genetic Testing in Miscarriage The Skinny: Genetic testing of miscarriage tissue is controversial and some people question if testing is helpful or not. This summary will: 1) outline the arguments for and against genetic testing; 2)

More information

ST. VINCENT'S. MEDICAL CENTER St. Vincent's Healthcare

ST. VINCENT'S. MEDICAL CENTER St. Vincent's Healthcare ST. VINCENT'S MEDICAL CENTER St. Vincent's Healthcare Medical Technology St. Vincent s Schools of Medical Science Throughout Northeast Florida and Southern Georgia, St. Vincent s HealthCare is well known

More information

JOINT COMMISSION INTERNATIONAL ACCREDITATION STANDARDS FOR. 2nd Edition

JOINT COMMISSION INTERNATIONAL ACCREDITATION STANDARDS FOR. 2nd Edition JOINT COMMISSION INTERNATIONAL ACCREDITATION STANDARDS FOR CliniCAl laboratories 2nd Edition Effective 1 April 2010 International Patient Safety Goals (IPSG) Goals The following is a list of all goals.

More information

A 28 year old woman, gravida 2, para 1, at 16 weeks gestation informs you that her cat, which she has owned for several years, has toxoplasmosis, as

A 28 year old woman, gravida 2, para 1, at 16 weeks gestation informs you that her cat, which she has owned for several years, has toxoplasmosis, as A 28 year old woman, gravida 2, para 1, at 16 weeks gestation informs you that her cat, which she has owned for several years, has toxoplasmosis, as diagnosed from a stool sample. She is concerned about

More information

Urinalysis and Body Fluids CRg. Synovial Fluid. Synovial Fluid. Unit 4. Composition and formation. Functions. Reasons for analysis.

Urinalysis and Body Fluids CRg. Synovial Fluid. Synovial Fluid. Unit 4. Composition and formation. Functions. Reasons for analysis. Urinalysis and Body Fluids CRg Unit 4 Synovial Fluid Synovial Fluid Composition and formation Secreted by cells of synovial membrane Very viscous, clear ultrafiltrate of plasma Contains Hyaluronic acid

More information

Implementation Guide

Implementation Guide HAWAII HEALTH INFORMATION CORPORATION HAWAII S SOURCE FOR HEALTHCARE Implementation Guide ASCII HL7 Specifications for Laboratory Observation Reporting Technical Specifications and Transmittal Instructions

More information

IMMUNOASSAY CONTROL - LEVEL 1 (IA CONTROL 1)

IMMUNOASSAY CONTROL - LEVEL 1 (IA CONTROL 1) 0843 IMMUNOASSAY CONTROL - LEVEL 1 (IA CONTROL 1) Cat. No. IA2638 / IA2633 Lot No. 978EC Size: 10 x 5 ml / 12 x 5 ml Expiry: 2013-10 INTENDED USE This product is intended for in vitro diagnostic use in

More information

EUROTUBO DELTALAB 6. SWABS

EUROTUBO DELTALAB 6. SWABS 92 93 94 The swab, sterile or non sterile, is used for biological sample collection. Specially used for processing samples which, after being coloured, will be analysed by microscopy. Also suitable for

More information

Contents. Abstract... i. Committee Membership... iii. Foreword... vii. 1 Scope... 1. 2 Introduction... 1. 3 Standard Precautions...

Contents. Abstract... i. Committee Membership... iii. Foreword... vii. 1 Scope... 1. 2 Introduction... 1. 3 Standard Precautions... Vol. 28 No. 20 Replaces H47-A Vol. 16 No. 3 One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test; Approved Guideline Second Edition This document provides guidelines

More information

What Do Those Lab Tests Mean?

What Do Those Lab Tests Mean? What Do Those Lab Tests Mean? This information is not meant to be a substitute for veterinary care. Always follow the instructions provided by your veterinarian. The results of laboratory tests on a patient

More information

Multiple Myeloma Patient s Booklet

Multiple Myeloma Patient s Booklet 1E Kent Ridge Road NUHS Tower Block, Level 7 Singapore 119228 Email : ncis@nuhs.edu.sg Website : www.ncis.com.sg LIKE US ON FACEBOOK www.facebook.com/ nationaluniversitycancerinstitutesingapore Multiple

More information

An Overview of Mayo Clinic Tests Designed for Detecting Drug Abuse

An Overview of Mayo Clinic Tests Designed for Detecting Drug Abuse Drug Testing An Overview of Mayo Clinic Tests Designed for Detecting Drug Abuse Printed on August 18, 2016 1:59 pm CST 2016 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.

More information

Interpretation of Laboratory Values

Interpretation of Laboratory Values Interpretation of Laboratory Values Konrad J. Dias PT, DPT, CCS Overview Electrolyte imbalances Renal Function Tests Complete Blood Count Coagulation Profile Fluid imbalance Sodium Electrolyte Imbalances

More information

Direct Testing Systems and Serology

Direct Testing Systems and Serology Direct Testing Systems and Serology Rapid Manual Tests 6-2 Serology Diagnostics 6-6 BD Diagnostics Diagnostic Systems Catalog 2005/2006 6-1 Rapid Manual Tests Meningitis Test Systems 252360 Directigen

More information

SAMPLE PROCEDURE 1029-3, 09/11

SAMPLE PROCEDURE 1029-3, 09/11 SAMPLE PROCEDURE This Sample Procedure is not intended as a substitute for your facility s Procedure Manual or reagent labeling, but rather as a model for your use in customizing for your laboratory s

More information

Manitoba Monthly Surveillance Unit Report

Manitoba Monthly Surveillance Unit Report Manitoba Monthly Surveillance Unit Report Reported up to October 31, 2011 Highlights: 1. Antimicrobial Resistant Organisms Together Methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials Additional copies of this guidance are available from the Office

More information

The concept of a critical value as a laboratory result that

The concept of a critical value as a laboratory result that Does Routine Repeat Testing of Critical Values Offer Any Advantage Over Single Testing? Adam D. Toll, MD; Jennifer M. Liu, MD; Gene Gulati, PhD; Eric M. Behling, MD; William D. Kocher, MD N Context. Before

More information

CHROMOSOMES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA

CHROMOSOMES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA CHROMOSOMES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA Cytogenetics is the study of chromosomes and their structure, inheritance, and abnormalities. Chromosome abnormalities occur in approximately:

More information

WHICH SAMPLES SHOULD BE SUBMITTED WHEN LYMPHOID NEOPLASIA IS SUSPECTED?

WHICH SAMPLES SHOULD BE SUBMITTED WHEN LYMPHOID NEOPLASIA IS SUSPECTED? WHICH SAMPLES SHOULD BE SUBMITTED WHEN LYMPHOID NEOPLASIA IS SUSPECTED? Which test should be submitted? The answer to this depends on the clinical signs, and the diagnostic question you are asking. If

More information

Professional Product List 2015

Professional Product List 2015 Trade diagnostical products for clinical laboratories products for life. Professional Product List 2015 CLINICAL CHEMISTRY Occupational Medicine Drugs of Abuse TDM High Diagnostic Sensitivity and Specificity

More information

Core Functions and Capabilities. Laboratory Services

Core Functions and Capabilities. Laboratory Services Core Functions and Capabilities British Columbia Centre for Disease Control Laboratory Services Understanding the role and value of British Columbia s public health laboratory in protecting our community

More information

Medical Laboratory Technician

Medical Laboratory Technician Medical Laboratory Technician Dr. Karen Escolas, Chair Medical Laboratory Technology Dept. karen.escolas@farmingdale.edu 631-420-2257 School of Health Sciences Associate in Science Degree The Medical Laboratory

More information

General Information. Our Background Automated Phone Services Holiday Coverage Licenses & Accreditations

General Information. Our Background Automated Phone Services Holiday Coverage Licenses & Accreditations General Information Our Background Automated Phone Services Holiday Coverage Licenses & Accreditations Our Background Foundation Laboratory is an advanced, accredited and certified clinical diagnostic

More information

Urinalysis and Body Fluids CRg. Overview of Body Fluid Analysis. Cerebrospinal Fluid (CSF) Unit 4. Composition and formation. Cerebrospinal Fluid

Urinalysis and Body Fluids CRg. Overview of Body Fluid Analysis. Cerebrospinal Fluid (CSF) Unit 4. Composition and formation. Cerebrospinal Fluid Urinalysis and Body Fluids CRg Unit 4 Cerebrospinal Fluid Overview of Body Fluid Analysis Laboratory responsibilities Accurate & timely results Source of information Normal values Reliability of results,

More information

laboratorymedicine> august 2001> number 8> volume 32

laboratorymedicine> august 2001> number 8> volume 32 interpretation [management/administration and training generalist] A Four-Part Approach to Competency Assessment Jennifer Schiffgens, MBA, MT(ASCP), 1 and Valerie Bush, PhD, MT(ASCP) 2 From 1 Clinical

More information

MHDO CompareMaine Updated: 9/17/2015

MHDO CompareMaine Updated: 9/17/2015 Office Visits -- Adult Preventative Care Office Visit (or Wellness Office Visit) 99385 New patient preventive care visit for adult, ages 18 to 39 99386 New patient preventive care visit for adult, ages

More information

Acute myeloid leukemia (AML)

Acute myeloid leukemia (AML) Acute myeloid leukemia (AML) Adult acute myeloid leukemia (AML) is a type of cancer in which the bone marrow makes abnormal myeloblasts (a type of white blood cell), red blood cells, or platelets. Adult

More information

Quality Corner. Laboratory Information System and Electronic Medical Records Backup and Computer Down By Rhonda Burgard, Client Services Supervisor

Quality Corner. Laboratory Information System and Electronic Medical Records Backup and Computer Down By Rhonda Burgard, Client Services Supervisor Page 1 of 7 Volume 8 Issue 44 401 North 9 th Street, Bismarck ND 58501-4507 June 2012 Quality Corner Laboratory Information System and Electronic Medical Records Backup and Computer Down When quality control,

More information

Rapid Screening Tests

Rapid Screening Tests Rapid Screening Tests Infectious Diseases Cardiac Marker Tumor Markers Pregnancy Rheumatology Allergy Drugs of Abuse > For rapid and cost-effective diagnosis > Accurate, reliable results > Easy to use

More information

And Now, Presenting...

And Now, Presenting... Presentation and Handling of Clinical Laboratory Data From Test Tube to Table Randall K. Carlson, Wilmington, DE and Nate Freimark, Lakewood, NJ Omnicare Clinical Research. Inc. INTRODUCTION In human clinical

More information

Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology

Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology INTRODUCTION 2009 A university wishing to have an accredited program in Pediatric Hematology/Oncology must also

More information

Laboratory Services Policy

Laboratory Services Policy Policy Number 2014R0014F Annual Approval Date Laboratory Services Policy 1/27/2014 Approved By National Reimbursement Forum United HealthCare Community & State Payment Policy Committee IMPORTANT NOTE ABOUT

More information